A neurologist's personal battle against Alzheimer's disease
Perhaps the biggest Alzheimer’s news in 2021 was the controversial FDA approval of the anti-amyloid monoclonal antibody Aduhelm (aducanumab). Controversy surrounds the mixed results of two parallel phase 3 trials. Both trials showed efficacy at removing...
Among the lifestyle modifications that can reduce the risk of Alzheimer’s and slow its progression is adherence to a Mediterranean-style diet. The MIND diet (Mediterranean-DASH Intervention for Neurodegenerative Delay) is an amalgam of the...
We’ve talked a lot so far about clinical trials of several so-called disease-modifying drugs for Alzheimer’s disease. These are medications designed to slow and perhaps even stop the progression of Alzheimer’s. Most of them so...
Recent Comments